Eutilex, a Korean biotech firm, said it would conduct a clinical trial to develope a home-grown chimeric antigen receptor T cell (CAR-T) therapy. The company said on Wednesday the Ministry of Food and Drug Safety approved its plan to test EU307, an investigational CAR-T therapy in hepatocellular car
KAIST said on Wednesday that its researchers identified mutations present in trace amounts of brain cells in patients with local cortical dysplasia, an intractable epilepsy in children, laying the foundation for developing a treatment.Epilepsy is a neurological disorder characterized by repeated sei
As Samsung Bioepis won in the first trial to invalidate the patent of Alexion's rare intractable blood disease treatment Soliris (ingredient: eculizumab) in Korea, the possibility of Samsung Bioepis launching SB12, a biosimilar referencing Soliris in Korea has increased.To sell biosimilars, which ar
A team of researchers at the Korea Institute of Science and Technology (KIST) said they developed a biosensor that can distinguish small molecular neurotransmitters from body fluids like cerebrospinal fluids.Recently, excessive stress and increased life expectancy have caused an increase in mental d
Researchers in Korea have conducted a study that showed that regular exercise in type 2 diabetic patients reduces the risk of atrial fibrillation (AF), a type of arrhythmia that is the main cause of sudden death.Atrial fibrillation (AF) is a type of arrhythmia that causes rapid and irregular pulses
Samsung Biologics has officially asked the latecomer Lotte Biologics to stop talent poaching amid ongoing disputes over whether three ex-Samsung employees leaked Samsung’s trade secrets to Lotte, Yonhap News reported on Thursday. Samsung Biologics has sent three packs of certified mail to Lotte Biol
GenNBio expressed its goal to lead clinical trials of xenotransplantation of pancreatic islets globally and develop new treatment options for incurable diseases.The company held a press conference on Wednesday to update its development of pig pancreatic islet transplantation. The company hopes that
Celltrion Healthcare said it has recently hired Thomas Nusbickel, who has worked at multinational drugmakers such as Amgen and Pfizer, as Chief Commercial Officer (CCO) of Celltrion USA.According to Celltrion Healthcare, new CCO Nusbickel is an expert in sales, marketing, market access, and governme
As large Korean CDMO companies, including Samsung Biologics and Lotte Biologics, vie to expand manufacturing facilities, their competition has moved to recruit a specialized workforce, an industry group said.In its Issue Briefing on Monday, KoreaBIO pointed to the shortage of experienced workers in
SK Bioscience said it had demonstrated global-level performance in ESG (environmental, social, and corporate governance) management, but the company’s rating in the MSCI ESG rating remained at an average level, it was learned.In a news release Friday, SK Bioscience said it won a BBB rating in the ES
Lotte Biologics said it is opting to build its mega plant in Songdo, Incheon.Lotte Biologics said it had submitted a letter of intent to Songdo International Business District (IBD).“We submitted documents indicating our intention to build our operation base in Songdo,” a company official said. “The
KAIST said on Wednesday that its researchers identified a post-translational modification (PTM) code that can help to suppress cancer and other brain-related diseases.PTM refers to the translation process of the mRNA molecule into the final protein which affects its structure and efficacy of the pro
NewG Lab Pharma's stock price plunged by nearly 50 percent in two days, raising questions among industry watchers.At 11 a.m. Monday, the company shares stood at 6,560 won ($5.33), down by 1,560 won, or 19.41 percent, from 8,140 won the previous trading day’s closing price.The stock price of NewG Lab
Large traditional Korean pharmaceutical companies, such as Chong Kun Dang, Dong-A ST, and Samchundang Pharmaceutical, are accelerating their entry into the biosimilar market.According to industry watchers, local pharmaceutical companies are zeroing in on the growth potential of biosimilars as blockb
Two Kosdaq-listed companies, Avion and Gencurix, have been accused of violating trade secrets on cancer diagnosis-related technology in the United States.According to industry sources on Monday, trade secrets infringement lawsuits against Avion and Zencurix are currently underway in U.S. courts. The
Korea Advanced Institute of Science & Technology (KAIST) said on Monday that its researchers published a study on a technology that can change the properties of lung cancer cells to revert metastasis and lower drug resistance.The epithelial-to-mesenchymal transition (EMT) of primary cancer leads to
CJ Bioscience continued to show sluggish performance in 2022 even after CJ Group, a Korean conglomerate, acquired the company.CJ Group acquired Chunlab, which specializes in microbiome treatment, in January last year and restarted its bio-business after renaming the company to CJ Bioscience.At that
Koreans in their 30s and 40s will likely be the first generation to age faster than their parents because they are exposed to an “accelerated aging environment,” an expert said.Professor Jung Hee-won of Geriatric Medicine at Asan Medical Center (AMC) in Seoul said so at a round-table meeting hosted
SK Bioscience said CEO Ahn Jae-yong presented global partnership strategies for overcoming the next pandemic by establishing regional vaccine hubs at the 2023 Riyadh Global Medical Biotechnology Summit in Riyadh, Saudi Arabia, on Wednesday.The Riyadh Summit is a national event where global bioindust
HK inno.N said it has signed an exclusive license agreement with Spain's mAbxience to market the latter's Prolia (ingredient: denosumab) biosimilar, a preventive treatment for osteoporosis and cancer-related skeletal complications, in Korea.Under the contract, HK inno.N will exclusively market two t